Skip to main content

Closed

PYPD: PolyPid Ltd. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+0.0% / yr

Operating margin0.0%

ROIC-114.3%

Financially safe

Stretched

Debt / equity0.27×

Interest coverage-29.5×

Current ratio1.78×

PolyPid Ltd.

PYPDNASDAQ Global Market·USD·Closed

PolyPid Ltd.

PYPDNASDAQ·USD·Closed

$4.29

−1.83%

$4.29

−$0.08 (1.83%)

52W Range

46thpctl

Volume

0.54×avg

Mkt Cap

43.72MUSD

P/E

-2.2TTM

Div Yield

–ann

52W Range

46thpctl

Volume

0.54×avg

Market Cap

43.72MUSD

P/E Ratio

-2.2TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings